Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B

Conditions

• Congenital Bleeding Disorder
• Haemophilia A
• Haemophilia B

Interventions

• DRUG: activated recombinant human factor VII

Sponsor

Novo Nordisk A/S